Helping technical founders turn breakthrough science into commercial success.
Executive level advisory for founder-led biotech and AI platform companies navigating fundraising, productization, and commercialization—built on two decades of translating complex science into commercial execution.
$100M+
Collaboration realigned for ROI
20+ years
Genomics, alliances & commercial ops
120%+
commercial targets, $36M in execution
Who I Help
I partner with technical founder-led biotech and AI platform companies, typically Seed through Series B, navigating critical inflection points.
Whether you're preparing to raise capital, launch a platform, build strategic partnerships, or commercialize new technology, I help turn strategy into focused execution.
Fundraising readiness
Productization
Commercialization Translation
Selected Experience
Over two decades leading strategy, partnerships, commercialization, and execution across genomics, diagnostics, and emerging life science technologies.
What I Do
Strategic Execution
Turn strategy into action by aligning priorities, teams, and execution around what matters most.
Case Study:
Aligning Strategic Partnerships
Challenge
A three-party collaboration had become misaligned.
Action
Redesigned governance and operating structure.
Outcome
~$8M in projected cost savings.
Fundraising & Commercial Readiness
Build investor-ready milestones, commercialization plans, and partnership strategies that support growth.
Case Study:
Advising Early Stage Founders
Challenge
Support commercialization of an early-stage AI startup.
Action
Advised on market positioning and KOL strategy.
Outcome
Supported a successful seed financing.
Case Study:
Building New Revenue Streams
Challenge
Build new partnership Fill in here ABC
Action
Created commercial infrastructure and strategic partnerships.
Outcome
$400K in new business within six months.
Product Strategy & Partnerships
Translate innovative science into clear customer value through product positioning, strategic partnerships, and commercialization planning.
Case Study:
Emerging Platform Commercialization
Challenge
A breakthrough platform needed stronger commercial traction.
Action
Developed use cases, customer strategy, and early commercial partnerships.
Outcome
Positioned the platform across oncology, neuroscience, and aging research.
How I Work
For founders who have a sense of what they need to do, and need a clear path to get there.
We start with structured conversations across your team and key stakeholders, mapping where initiatives, ownership, and priorities are actually breaking down—not just where they appear to be. From there, I identify the highest-leverage bottlenecks and build a 30/60/90 plan that tells you exactly what to fix first, and why.
You leave with a clear diagnosis and a concrete roadmap—whether or not we work together beyond this engagement.
Timeline: 2–3 weeks
For teams moving through a transition—fundraising, launch, or scaling—that need results fast.
This is hands-on work. I step in alongside your team to close the specific gaps slowing you down—sharpening your narrative for investors, translating platform capability into a commercialization story, or resolving the cross-functional friction nobody's had time to untangle.
Timeline: 4–6 weeks
For founders in active scale-up who need an ongoing strategic sounding board and hands-on guidance.
As your company grows, new problems surface faster than you can solve them alone. I work alongside you on an ongoing basis—helping prioritize, resolve escalations, and keep execution moving as the company scales.
Timeline: Monthly
About Kat
With humble origins in Kauai's "Biggest Littlest Town," my path has taken me from engineer to scientist to business and strategy leader—spending more than 20 years at the intersection of genomics, life sciences, business, and emerging technology.
I do my best work at the front end: diagnosing challenges, identifying opportunities, and shaping strategies that translate into real-world impact. I thrive in environments that are ambiguous, fast-moving, cross-functional, and intellectually complex. Outside of work, the ocean keeps me grounded—a reminder to stay curious, adaptable, and connected to the bigger picture.
FAQ
-
No. Some founders already know exactly where the gap is and want to move straight to a Sprint or Retainer. The Assessment is there for founders who want a clear diagnosis first.
-
A fractional COO typically owns ongoing operations. I come in around specific transitions and gaps—diagnosing what's broken, executing the fix, and handing off—with the option to stay on if there's ongoing need.
-
Technical founder-led biotech and AI platform companies, typically Seed through Series B.
-
Primarily remote, with on-site availability for key working sessions as needed.
-
Book a call. We'll talk through where things stand and determine which engagement—or custom mix—makes the most sense.